Bpifrance invests in Softway Medical Group to enhance its growth potential in the European e-health sector alongside leading private equity firms.
Target Information
Softway Medical Group is a leading European provider of health information systems, operating as a publisher, host, and integrator for both public and private healthcare institutions across France, Canada, and Europe. With its headquarters located in Fuveau, France, and a workforce exceeding 1,200 employees, the group offers a comprehensive suite of cloud-native e-health solutions. These include Electronic Patient Records (EPR), Patient Administration Management systems (PAM), and integrated management software tailored to meet the needs of healthcare providers. As a trusted partner for thousands of healthcare establishments, including public and private hospitals, imaging centers, laboratories, and independent practitioners, Softway Medical has experienced robust organic growth over the past decade.
In addition to being a solid leader in France, the group is actively expanding its international footprint. With a strong presence in Belgium and Canada, Softway Medical is strategically positioned to penetrate new markets worldwide by capitalizing on its cutting-edge web platform and understanding of customer needs.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare technology sector in France has witnessed considerable growth, underpinned by increasing demands for digital health solutions that enhance patient outcomes and streamline operations in healthcare facilities. The French governm
Similar Deals
Kemin Industries → AFYREN
2025
GENEO Capital Entrepreneur → MLab
2025
Vivalto Santé → 3 establishments in France and 7 establishments in Europe
2024
Turenne Santé, Sodero → Vedalab
2024
Nord Est Partenaires, Carvest → HTC Santé
2024
Bpifrance
invested in
Groupe Softway Medical
in 2025
in a Growth Equity & Expansion Capital deal